3-24117156-C-T

Variant names:

• chr3-24117156-C-T
• rs17014136
• NM_001354712.2:c.*5728G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_001354712.2(THRB):​c.*5728G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.186 in 152,142 control chromosomes in the GnomAD database, including 3,019 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.19 (3018 hom., cov: 32)
  • Exomes 𝑓: 0.50 (1 hom.)
• Consequence: THRB NM_001354712.2 3_prime_UTR
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: -3.16
• Publications: 2 publications found

Genes affected

THRB (HGNC:11799): (thyroid hormone receptor beta) The protein encoded by this gene is a nuclear hormone receptor for triiodothyronine. It is one of the several receptors for thyroid hormone, and has been shown to mediate the biological activities of thyroid hormone. Knockout studies in mice suggest that the different receptors, while having certain extent of redundancy, may mediate different functions of thyroid hormone. Mutations in this gene are known to be a cause of generalized thyroid hormone resistance (GTHR), a syndrome characterized by goiter and high levels of circulating thyroid hormone (T3-T4), with normal or slightly elevated thyroid stimulating hormone (TSH). Several alternatively spliced transcript variants encoding the same protein have been observed for this gene. [provided by RefSeq, Jul 2008]

THRB Gene-Disease associations (from GenCC):

• thyroid hormone resistance, generalized, autosomal dominant

  Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
• resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta

  Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
• thyroid hormone resistance, generalized, autosomal recessive

  Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

ACMG classification

Our verdict: Benign. The variant received -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.92).
• BP6: Variant 3-24117156-C-T is Benign according to our data. Variant chr3-24117156-C-T is described in ClinVar as Benign. ClinVar VariationId is 344532.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.283 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001354712.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	THRB	NM_001354712.2	MANE Select	c.*5728G>A		3_prime_UTR	Exon 11 of 11	NP_001341641.1	P10828-1
	THRB	NM_000461.5		c.*5728G>A		3_prime_UTR	Exon 10 of 10	NP_000452.2
	THRB	NM_001128176.3		c.*5728G>A		3_prime_UTR	Exon 11 of 11	NP_001121648.1	P10828-1

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	THRB	ENST00000646209.2	MANE Select	c.*5728G>A		3_prime_UTR	Exon 11 of 11	ENSP00000496686.2	P10828-1
	THRB	ENST00000396671.7	TSL:5	c.*5728G>A		3_prime_UTR	Exon 10 of 10	ENSP00000379904.2	P10828-1

Frequencies

GnomAD3 genomes AF: 0.186 AC: 28317 AN: 152020 Hom.: 3016 Cov.: 32

Gnomad AFR AF: 0.288

Gnomad AMI AF: 0.109

Gnomad AMR AF: 0.197

Gnomad ASJ AF: 0.195

Gnomad EAS AF: 0.0493

Gnomad SAS AF: 0.220

Gnomad FIN AF: 0.0977

Gnomad MID AF: 0.168

Gnomad NFE AF: 0.145

Gnomad OTH AF: 0.183

GnomAD4 exome AF: 0.500 AC: 2 AN: 4 Hom.: 1 Cov.: 0 AF XY: 0.500 AC XY: 2 AN XY: 4

African (AFR) AC: 0 AN: 0

American (AMR) AC: 0 AN: 0

Ashkenazi Jewish (ASJ) AC: 0 AN: 0

East Asian (EAS) AC: 0 AN: 0

South Asian (SAS) AC: 0 AN: 0

European-Finnish (FIN) AC: 0 AN: 0

Middle Eastern (MID) AC: 0 AN: 0

European-Non Finnish (NFE) AF: 0.500 AC: 2 AN: 4

Other (OTH) AC: 0 AN: 0

GnomAD4 genome AF: 0.186 AC: 28346 AN: 152138 Hom.: 3018 Cov.: 32 AF XY: 0.185 AC XY: 13780 AN XY: 74402

African (AFR) AF: 0.288 AC: 11932 AN: 41486

American (AMR) AF: 0.197 AC: 3014 AN: 15298

Ashkenazi Jewish (ASJ) AF: 0.195 AC: 678 AN: 3472

East Asian (EAS) AF: 0.0492 AC: 255 AN: 5184

South Asian (SAS) AF: 0.220 AC: 1062 AN: 4818

European-Finnish (FIN) AF: 0.0977 AC: 1035 AN: 10596

Middle Eastern (MID) AF: 0.156 AC: 46 AN: 294

European-Non Finnish (NFE) AF: 0.145 AC: 9844 AN: 67970

Other (OTH) AF: 0.180 AC: 381 AN: 2112

Alfa AF: 0.162 Hom.: 2783

Bravo AF: 0.197

Asia WGS AF: 0.139 AC: 481 AN: 3478

ClinVar

ClinVar submissions as Germline

Significance: Benign

Revision: criteria provided, multiple submitters, no conflicts

Pathogenic	VUS	Benign	Condition
-	-	1	not provided (1)
-	-	1	Thyroid hormone resistance, generalized, autosomal dominant (1)

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.92
CADD	Benign	0.097
DANN	Benign	0.38
PhyloP100		-3.2

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs17014136; hg19: chr3-24158647;